We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Abbott’s Topera Buy Threatens to Upset Current A-Fib Space
Abbott’s Topera Buy Threatens to Upset Current A-Fib Space
Abbott’s $250 million purchase of Topera, announced Wednesday, has significant implications for both Abbott and other devicemakers in the atrial fibrillation space, analysts say.